NMLSF

Healthcare Biotechnology

Restart Life Sciences Corp.

$0.07

+0.00 +7.03% today

Price History

Not enough data

Key Stats

Market Cap

4.09M

Avg Volume

1,286

EPS

-$0.02

52W High

$0.12

52W Low

$0.01

Div. Yield

0.0%

Valuation

P/B Ratio

4.42

P/S Ratio

8.81

EV/EBITDA

-2.11

EV/Revenue

7.92

Margins

Gross Margin 41.4%

Operating Margin (293.7%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(246.7%)

Return on Assets

(100.4%)

Liquidity & Leverage

Current Ratio

1.85

Quick Ratio

1.54

Debt / Equity

0.26

Total Cash

762,363

Total Debt

348,345

About

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company in Canada. It engages in research and development of psilocybin; and fund food-related research initiative in support of its expanding portfolio of consumer health and wellness products. The company has collaboration with the University of Manitoba's Richardson Centre for food technology and research (RCFTR) to support a series of food-related scientific studies, including the development across various product lines, including BrainQ, BrainBalls, and Holy Crap. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.